AHA Center for Health Innovation Market Scan
AHA Center for Health Innovation’s Market Scan articles provide insights and analysis on the field’s latest developments in health care disruption, transformation and innovation.
Read the latest newsletters and subscribe to Market Scan.
Download the full Market Scan Trailblazers report “Elevating Patient Access and the Consumer Experience” to learn more about what can be done to improve patient access and elevate the patient experience.
Health care executives continue to place a high priority on digital, artificial intelligence (AI) and analytics transformation, but 75% lack sufficient resources or planning in this area according to recent McKinsey & Company survey report.
The recently released third installment of the 2024 National Consumer Survey Series from Jarrard Inc., a Chartis Company, explores what leads patients to choose providers, how patients want to access care and what they want in their relationship with providers.
Holoconnects' Holobox hologram displays a lifelike 3D image of the physician and fosters a sense of connection with medical professionals even when they cannot be physically present.
Integrating artificial intelligence (AI) and automated workflows have significant potential to improve health care operations, particularly in revenue-cycle management (RCM). And with third-party payer denials and the rising cost of collections, providers increasingly are exploring solutions.
The most obvious entry point for xAI in health care will be similar to what other tech giants are doing, notes Forbes contributor Sai Balasubramanian, M.D., J.D.: Increase task automation, improve clinical workflows and optimize clinician productivity.
C-suite executives will need to realize cost reductions of 15% to 20% by 2030 to create a foundation for long-term financial sustainability, a new Oliver Wyman analysis suggests.
About one in five consumers switched providers in the past year and nearly 90% said they did so because the organization was hard to do business with, notes a recent Accenture report.
Glucagon-like peptide-1 agonist drugs have been surging in popularity, and manufacturers are scurrying to keep up with demand. Overall, the GLP-1 market is expected to experience annual growth exceeding 20% and will hit $133 billion worldwide by 2030, according to a MarketWatch report from February…
A new AHA Center for Health Innovation Leadership Scan episode, “Revolutionizing Revenue Cycle Management (RCM) Efficiency with AI,” will share insights on how AI solutions can help hospitals and health systems overcome staffing challenges in critical RCM areas to respond more efficiently to payer…